- Your cart is empty
- Continue Shopping
AccuDx CQ HsCRP (25 Test)
₹10,181.00
Overview
Buy ACCUDx CQ hs CRP+CRP Kit (Immunofluorescence Assay) used for the determination of
C-reactive protein (CP)
in serum, plasma or whole blood. Measurement of hscrp levels are useful for the detection and evaluation of infection, tissue injury and inflammatory disorders.
Measurement of hscrp meaning High-sensitivity C-reactive protein (hsCRP), when used in conjunction with traditional clinical laboratory evaluation of acute coronary syndromes (ACS), may be useful as an independent marker of prognosis for recurrent events in patients with stable coronary disease or ACS. High level of hs CRP in the blood has results in increased risk of heart attacks.
50 in stock
About
ACCUDx CQ hs-CRP+CRP Kit (Immunofluorescence Assay) is intended for in vitro quantitative determination of C-reactive protein (CP) in serum, plasma or whole blood. Measurement of CRP is useful for the detection and evaluation of infection, tissue injury and inflammatory disorders. Measurement of high sensitivity CRP (hs-CRP), when used in conjunction with traditional clinical laboratory evaluation of acute coronary syndromes (ACS), may be useful as an independent marker of prognosis for recurrent events in patients with stable coronary disease or ACS.
INTRODUCTION
C-reactive protein is an acute-phase reactant that precipitates with Pneumococcal -polysaccharide and is a non-specific immune response component. CRP has wide distribution in our body and is an acute-viiase protein produced in the liver in response to microbial infection or tissue injury. hs-CRP can be used to detect lower concentrations of CRP in serum, plasma or whole blood. Studies reveal that hs-CRP levels correlate with Atherosclerosis and Acute Myocardial Infarction, hs-CRP is an inflammation
“”marker”” for ACS and is helpful for primary risk assessment of cardiovascular disease. Its combination with the ratio of total cholesterol to HDL-C is more accurate than other risk factor in predicting cardiovascular disease.
The American Heart Association and US Centers for Disease Control and Prevention have advocated hs-CRP as a predictor of cardiovascular disease (CVD) to define risk groups: less than 1.0 mg/L indicates low risk, 1.0 to 3.0 mg/L means moderate risk, and above 3.0 mq/L (lower than 10mg/L) strongly suggests a high risk of CV/D. Moreover, highe: CRP levels are found in late pregnant women, mild inflammation and viral infections (10-40 mg/L). active inflammation, bacterial infection (40-200 mg/L), severe bactenalinfections and burns (>200 mg/L).
TEST RESULTS:
ACCUDx CQ Analyzer can scan the test card automatically and display the result on the screen. For additional information, please refer to the user manual of ACCUDx CQ Analyzer”
Specification
The test uses an anti-human CRP monoclonal antibody conjugated with fluorescence latex and another anti-human CP monoclonal antibody coated on the test line. After the sample has been applied to the test strip, the fluorescence latex-labelled anti-human CRP monoclonal antibody binds with the CRP in sample and forms a marked antigen-antibody complex. This complex moves to the test detection zone by capillary action. Then, the marked antigen-antibody complex is captured on the test line by the anti-human CRP monoclonal antibody. The fluorescence intensity of the test Nine increases in proportion to the amount of CRP in sample. Then, the test card is inserted into ACCUDx CQ Immunofluorescence Quantitative Analyzer. The concentration of CRP in sample will be measured and displayed on the screen. The value will be stored in ACCUDx CQ Analyzer. The result can be transmitted to the laboratory or hospital information system.”
Safety Information
PRECAUTIONS:
1. For in vitro diagnostic use only.
2. For professional use only.
3. Do not use the kit beyond the expiration date.
4. Do not use the test card if the foil pouch or the cartridge is damaged.
5. Do not open pouches or the cartridge until you are ready to perform test.
6. Do not reuse the test card.
7. Do not reuse the pipet tips.
8. Mandie ail specimens as potentially iniecious. Proper hendiing and disposal methods should be followed in acoordance with local regulations and good safety practices.
9. Carefully read and follow the user manual to ensure test performance.
Direction for Use
1. Collect specimens according to safe phlebotomy procedures.
2. Test card, sample and reagent should be brought to room temperature before testing
3. Confirm that SD card lot No. matches with the test kit lot No… Perform ‘SD Card Calib”” calibration whenever lot number is changed and when necessary.
4. On the main menu of ACCUDx CQ Analyzer, press “”ENT* button to enter testing interface.
5. Remove the test card from the sealed pouch just before use. Label the test card with patient or specimen identification.
on Standardization of Markers of Cardiac Damage. Clin Chem Lab Med,
1998, 36:887-893.
2. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task
Force on Pratice Guidelines (Committee to Revise the 1999 Guidelines
for the Manage 2004).
3. EN ISO 18113-1:2009 In vitro diagnostic medical devices – Information supplied by the manufacturer (labelling) – Part 1: Terms, definitions and
general requirements.
4. EN ISO 18113-2:2009 In vitro diagnostic medical devices – Information supplied by the manufacturer (labelling) – Part 2: In vitro diagnostic
reagents for professional use (ISO 18113-2:2009).”
Other Info
Store the test card at 4-30°C.
Use the lest card within 1 hour once the foil pouch is opened.
Store the whole blood buffer at 0-30°C. For better results, store the whole blood buffer at 2-8°C.
Aman –
Nice product